D. Zarca, M. Deloménie, P. Pujol, J. Klinkhamer, P. Cusumano
{"title":"在法国,MammaPrint®对原发性激素受体阳性、her2阴性和非转移性早期乳腺癌患者的预算影响","authors":"D. Zarca, M. Deloménie, P. Pujol, J. Klinkhamer, P. Cusumano","doi":"10.1016/s0960-9776(23)00283-7","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":22301,"journal":{"name":"The Breast : Official Journal of the European Society of Mastology","volume":"45 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"P166 Budget impact of MammaPrint® in Patients with primary hormone receptor-positive, HER2-negative and non-metastatic early-stage breast cancer in France\",\"authors\":\"D. Zarca, M. Deloménie, P. Pujol, J. Klinkhamer, P. Cusumano\",\"doi\":\"10.1016/s0960-9776(23)00283-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":22301,\"journal\":{\"name\":\"The Breast : Official Journal of the European Society of Mastology\",\"volume\":\"45 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Breast : Official Journal of the European Society of Mastology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/s0960-9776(23)00283-7\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Breast : Official Journal of the European Society of Mastology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s0960-9776(23)00283-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
P166 Budget impact of MammaPrint® in Patients with primary hormone receptor-positive, HER2-negative and non-metastatic early-stage breast cancer in France